
Elizabeth Brunk, PhD
Dr. Elizabeth Brunk, Assistant Professor of Chemistry and Pharmacology and member of iBGS, has received a Lung Cancer Research Foundation–Boehringer Ingelheim Early Investigator Award to investigate how extrachromosomal DNA (ecDNA) reshapes genome architecture and drives therapeutic resistance in lung cancer. Her laboratory combines artificial intelligence, single-cell genomics, imaging, and computational modeling to understand how cancer cells adapt to targeted therapies. The work will provide new insights into genome plasticity and may reveal new strategies for preventing treatment resistance in aggressive cancers.



